Professor of Medicine, Johns Hopkins University School of Medicine; Director, Center for the Chronic Myeloproliferative Disorders
Hematology
Dr. Jerry Spivak, MD
|
|
Give Review
Doctor Jerry Spivak, MD is an expert in the field of Hematology. He went to Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University is ranked 18/49 in Research/PrimaryCare. He received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer", "Top Doctors:Baltimore Area", "Top Doctors:Washington-Baltimore", "Investigator Alumnus" and "Super Doctor". Jerry Spivak is also published. He has 99 publications published. The lastest publication: "The erythropoietic mouse spleen-a model system of development.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Ruxolitinib Enhances Platelet Production in Patients With Thrombocytopenic Myelofibrosis.
- Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient iPSCs.
- Polycythaemia Vera.
- MicroRNA deregulation in Polycythemia vera and essential thrombocythemia patients.
- Could hypoxia increase the prevalence of thrombotic complications in Polycythemia vera?
- Age-related differences in disease characteristics and clinical outcomes in Polycythemia vera.
- Augmentation of anterior vertebral body screw fixation by an injectable, biodegradable calcium phosphate bone substitute.
- Instrumented posterior arthrodesis of the lumbar spine in patients with diabetes mellitus.
- Sickle cell Anemia and transposition of the great vessels.
- Erythropoietin: isolation by affinity chromatography with lectin-agarose derivatives.
- A simple hypoxic chamber.
- Lack of association of higher insulin levels with diffuse atherosclerotic coronary artery Disease in nondiabetics.
- Studies on splenic erythropoiesis in the mouse. I. Ribosomal ribonucleic acid metabolism.
- The erythropoietic mouse spleen-a model System of development.
- Hepatitis-related hepatic erythropoietin production.
- The haematological manifestations of acquired immune deficiency Syndrome.
- Felty''s Syndrome: an analytical review.
- Stimulation of erythroid colony formation in vitro by erythropoietin immobilized on agarose-bound lectins.
- Hematologic abnormalities in the acquired immune deficiency Syndrome.
- Sequential activation of splenic nuclear RNA polymerases by erythropoietin.
- Erythropoiesis in vitro. Role of calcium.
- Homosexual men with thrombocytopenia have impaired reticuloendothelial System Fc receptor-specific clearance.
- Letter: Kinetics of lymphocytes.
- Effect of phenylhydrazine-induced hemolytic Anemia on nuclear RNA polymerase activity of the mouse spleen.
- Use of immobilized lectins and other ligands for the partial purification of erythropoietin.
- Erythropoietin response to Anemia as a function of age.
- Calcium and the erythroblast.
- Protease activity in human urine erythropoietin preparations.
- Evaluation of 51Cr as a leucocyte label.
- Marrow Cell necrosis in anorexia nervosa and involuntary starvation.
- Clinical use of erythropoietin.
- Retroviral Diseases in hematology.
- Metabolism of recombinant human erythropoietin in the rat.
- Sports hematology: serious concept or trivial pursuit. Introduction.
- Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment.
- Violaceous plaques on the lower extremities. Cutaneous macroglobulinosis.
- Thymus-conditioned medium influences in vitro colony formation by hematopoietic progenitor Cells.
- Erythropoietin and the regulation of erythropoiesis.
- The biology and clinical applications of recombinant erythropoietin.
- Recombinant human erythropoietin therapy in end stage renal failure.
- Hemochromatosis.
- The in vivo metabolism of recombinant human erythropoietin.
- Erythropoietin: a brief review.
- The mechanism of action of erythropoietin.
- Hematophagic histiocytosis. A report of 23 new patients and a review of the literature.
- Recombinant erythropoietin.
- Rapid and definitive diagnosis of infectious Diseases using peripheral blood smears.
- Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation.
- Susceptibility to merocyanine 540-mediated photosensitization: a differentiation marker on murine hematopoietic progenitor Cells.
- Selective killing of leukemic Cells by merocyanine 540-mediated photosensitization.
- Differential sensitivity of mouse hematopoietic stem Cells to merocyanine 540.
- Defibrinogenation after intra-amniotic injection of hypertonic saline.
- Intravascular granulocyte kinetics in Acute leukemia.
- Sterospecific tissue uptake and nuclear accumulation of testosterone in the development of the mouse erythropoietic spleen.
- Tumor-promoting phorbol esters stimulate myelopoiesis and suppress erythropoiesis in cultures of mouse bone marrow Cells.
- Susceptibility to merocyanine 540-mediated photosensitization as a differentiation marker in murine hematopoietic stem Cells.
- Lymphocyte kinetics in Chronic lymphocytic leukaemia.
- Effect of erythropoietin on chromosomal protein synthesis.
- Interleukin 3 promotes the in vitro proliferation of murine pluripotent hematopoietic stem Cells.
- Suppression and potentiation of mouse hematopoietic progenitor Cell proliferation by ouabain.
- Separation of erythroid progenitor Cells in mouse bone marrow by isokinetic-gradient sedimentation.
- Masked megaloblastic Anemia.
- Relationships between thrombopoiesis and erythropoiesis: with studies of the effects of preparations of thrombopoietin and erythropoietin.
- Serum immunoreactive erythropoietin in health and Disease.
- Recombinant human erythropoietin and the Anemia of cancer.
- Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs, and erythropoietin level.
- Erythropoietin: a new paradigm.
- Tumor-promoting phorbol esters stimulate the proliferation of interleukin-3 dependent Cells.
- Suppression of hematopoietic-progenitor-Cell proliferation by ethanol and acetaldehyde.
- Effect of ethanol on thrombopoiesis.
- Regulation of hematopoiesis: helper and suppressor influences of the thymus.
- Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors.
- Ligand binding kinetics of a soluble full-length murine erythropoietin receptor.
- Polycythemia vera in an anephric man.
- Effects of the differentiating agent hexamethylene bisacetamide on normal and Myelodysplastic hematopoietic progenitors.
- Serum immunoreactive erythropoietin during the perioperative period.
- Current thinking and treatment practices in anaemia--an interactive poll.
- Erythropoietin use and abuse: When physiology and pharmacology collide.
- Cancer-related Anemia: its causes and characteristics.
- Hexamethylene bisacetamide in myelodysplastic Syndrome: effect of five-day exposure to maximal therapeutic concentrations.
- Application of recombinant human erythropoietin in oncology.
- Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to Anemia.
- Serum immunoreactive erythropoietin in HIV-infected patients.
- Treatment of the Anemia of chronic renal failure with subcutaneous recombinant human erythropoietin.
- Serum immunoreactive erythropoietin in patients with end stage renal Disease.
- Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men.
- The in vivo metabolism of recombinant human erythropoietin in the rat.
- The blood in Systemic disorders.
- The application of recombinant erythropoietin in anemic patients with cancer.
- Erythropoietin: from bench to bedside.
- Intracellular growth factors in polycythemia vera and other myeloproliferative Disorders.
- The clinical physiology of erythropoietin.
- Impaired erythropoietin response to Anemia after bone marrow transplantation.
- Tumor-promoting phorbol esters support the in vitro proliferation of murine pluripotent hematopoietic stem Cells.
- The expression and role of human erythropoietin receptor in erythroid and nonerythroid Cells.
- Anemia of cancer.
- Daily aspirin--only half the answer.
- Decreased erythropoietin response in patients with the Anemia of cancer.
Schools
Weill Cornell Medical College
Johns Hopkins Hospital
New York Hospital
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Central Nervous System Lymphoma
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Top Doctors:Baltimore Area
- Top Doctors:Washington-Baltimore
- Investigator Alumnus
- Super Doctor
Education
-
Johns Hopkins University -
New York Presbyterian Hospital - Cornell Campus -
Weill Cornell Medical College of Cornell University
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1083645303 | |
| NPPES Provider LastName | SPIVAK | |
| NPPES Provider FirstName | JERRY | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Hematology | |
| Total Claim Count | 59.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083645303 |
| Last Name Of The Provider | SPIVAK |
| First Name Of The Provider | JERRY |
| View All |
Similar Doctors
|
|
Dr. Panayotis Ledakis, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Streiff, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kathleen H. Burns, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gabriel Ghiaur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Brodsky, MD |
|
|
Dr. Charles S. Hesdorffer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin L. Maughan, MD |
|
|
Roisin M. Connolly, MB BS
This Doctor is OpenDoctor Recommended.
|